Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Yang, Su Jung ^a   Chen, Chen Yu ^b   Chang, Geen Dong ^c   Wen, Hui Chin ^b   Chen, Ching Yu ^b,d   Chang, Shi Chuan ^a   Liao, Jyh Fei ^a   Chang, Chung Ho ^b,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ADVANCED GLYCATION END PRODUCT; BETA METHYLCYCLODEXTRIN; CAVEOLIN 1; ENZYME INHIBITOR; MUTANT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE [NAD(P)H] OXIDASE INHIBITOR DPI; OXIDOREDUCTASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; TIRON; UNCLASSIFIED DRUG; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANTIOXIDANT; CHROMONE DERIVATIVE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; MORPHOLINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TYRPHOSTIN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; 3T3 CELL LINE; ADIPOCYTE; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

3T3 CELLS; ADIPOCYTES; ANIMALS; ANTIOXIDANTS; CAVEOLIN 1; CHROMONES; ENZYME ACTIVATION; GLYCEROLPHOSPHATE DEHYDROGENASE; GLYCOSYLATION END PRODUCTS, ADVANCED; MICE; MORPHOLINES; NADPH OXIDASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSCRIPTIONAL ACTIVATION; TYRPHOSTINS;

EID: 84874601476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058100     Document Type: Article

References (57)

1. Nass N, Bartling B, Navarrete Santos A, Scheubel RJ, Borgermann J, et al. (2007) Advanced glycation end products, diabetes and ageing. Z Gerontol Geriatr 40: 349-356.
2. Grillo MA, Colombatto S, (2008) Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases. Amino Acids 35: 29-36.
3. Lin L, Park S, Lakatta EG, (2009) RAGE signaling in inflammation and arterial aging. Front Biosci 14: 1403-1413.
4. Yan SF, Ramasamy R, Schmidt AM, (2009) Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med 87: 235-247.
5. Goh SY, Cooper ME, (2008) Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93: 1143-1152.
6. Mendez JD, Xie J, Aguilar-Hernandez M, Mendez-Valenzuela V, (2010) Trends in advanced glycation end products research in diabetes mellitus and its complications. Mol Cell Biochem 341: 33-41.
7. Ramasamy R, Yan SF, Schmidt AM, (2007) Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts. Mol Nutr Food Res 51: 1111-1115.
8. Urata Y, Yamaguchi M, Higashiyama Y, Ihara Y, Goto S, et al. (2002) Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages. Free Radic Biol Med 32: 688-701.
9. Wong RK, Pettit AI, Davies JE, Ng LL, (2002) Augmentation of the neutrophil respiratory burst through the action of advanced glycation end products: a potential contributor to vascular oxidant stress. Diabetes 51: 2846-2853.
10. Xu D, Kyriakis JM, (2003) Phosphatidylinositol 3′-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products. J Biol Chem 278: 39349-39355.
11. Li L, Renier G, (2006) Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression. Metabolism 55: 1516-1523.
12. Unoki H, Bujo H, Yamagishi S, Takeuchi M, Imaizumi T, et al. (2007) Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 76: 236-244.
13. Coughlan MT, Mibus AL, Forbes JM, (2008) Oxidative stress and advanced glycation in diabetic nephropathy. Ann N Y Acad Sci 1126: 190-193.
14. Mercier I, Jasmin JF, Pavlides S, Minetti C, Flomenberg N, et al. (2009) Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Lab Invest 89: 614-623.
15. Patel HH, Murray F, Insel PA, (2008) Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 48: 359-391.
16. Lajoie P, Goetz JG, Dennis JW, Nabi IR, (2009) Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J Cell Biol 185: 381-385.
17. Schwencke C, Braun-Dullaeus RC, Wunderlich C, Strasser RH, (2006) Caveolae and caveolin in transmembrane signaling: Implications for human disease. Cardiovasc Res 70: 42-49.
18. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, et al. (1994) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126: 111-126.
19. Green H, Meuth M, (1974) An established pre-adipose cell line and its differentiation in culture. Cell 3: 127-133.
20. Hamada Y, Araki N, Koh N, Nakamura J, Horiuchi S, et al. (1996) Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem Biophys Res Commun 228: 539-543.
21. Chen ZJ, Vetter M, Chang GD, Liu S, Che D, et al. (2004) Cyclophilin A functions as an endogenous inhibitor for membrane-bound guanylate cyclase-A. Hypertension 44: 963-968.
22. Vetter M, Chen ZJ, Chang GD, Che D, Liu S, et al. (2003) Cyclosporin A disrupts bradykinin signaling through superoxide. Hypertension 41: 1136-1142.
23. Wise LS, Green H, (1979) Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J Biol Chem 254: 273-275.
24. Toure F, Zahm JM, Garnotel R, Lambert E, Bonnet N, et al. (2008) Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem J 416: 255-261.
25. Brizzi MF, Dentelli P, Gambino R, Cabodi S, Cassader M, et al. (2002) STAT5 activation induced by diabetic LDL depends on LDL glycation and occurs via src kinase activity. Diabetes 51: 3311-3317.
26. Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, et al. (2006) Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 281: 13685-13693.
27. Cassese A, Esposito I, Fiory F, Barbagallo AP, Paturzo F, et al. (2008) In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J Biol Chem 283: 36088-36099.
28. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P, (2005) Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 25: 6391-6403.
29. Catarzi S, Biagioni C, Giannoni E, Favilli F, Marcucci T, et al. (2005) Redox regulation of platelet-derived-growth-factor-receptor: role of NADPH-oxidase and c-Src tyrosine kinase. Biochim Biophys Acta 1745: 166-175.
30. Santen RJ, Fan P, Zhang Z, Bao Y, Song RX, et al. (2009) Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and-resistant breast cancer cells. Steroids 74: 586-594.
31. Fagan DH, Yee D, (2008) Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 13: 423-429.
32. Du J, Sperling LS, Marrero MB, Phillips L, Delafontaine P, (1996) G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochem Biophys Res Commun 218: 934-939.
33. Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, et al. (2003) Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 81: 159-167.
34. Zahradka P, Litchie B, Storie B, Helwer G, (2004) Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase. Endocrinology 145: 2978-2987.
35. Bouallegue A, Vardatsikos G, Srivastava AK, (2009) Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells. Can J Physiol Pharmacol 87: 1009-1018.
36. Hallak H, Moehren G, Tang J, Kaou M, Addas M, et al. (2002) Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes. Hepatology 36: 1509-1518.
37. Ushio-Fukai M, (2009) Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 11: 1289-1299.
38. Li H, Han W, Villar VA, Keever LB, Lu Q, et al. (2009) D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells. Hypertension 53: 1054-1061.
39. Guichard C, Pedruzzi E, Dewas C, Fay M, Pouzet C, et al. (2005) Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem 280: 37021-37032.
40. Yang B, Rizzo V, (2007) TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 292: H954-962.
41. Huo H, Guo X, Hong S, Jiang M, Liu X, et al. (2003) Lipid rafts/caveolae are essential for insulin-like growth factor-1 receptor signaling during 3T3-L1 preadipocyte differentiation induction. J Biol Chem 278: 11561-11569.
42. Wu CH, Huang HW, Huang SM, Lin JA, Yeh CT, et al. (2012) AGE-induced interference of glucose uptake and transport as a possible cause of insulin resistance in adipocytes. J Agric Food Chem 59: 7978-7984.
43. Kawai M, Rosen CJ, (2010) PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6: 629-636.
44. Li S, Ferber A, Miura M, Baserga R, (1994) Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. J Biol Chem 269: 32558-32564.
45. Li W, Miller WT, (2006) Role of the activation loop tyrosines in regulation of the insulin-like growth factor I receptor-tyrosine kinase. J Biol Chem 281: 23785-23791.
46. Peterson JE, Jelinek T, Kaleko M, Siddle K, Weber MJ, (1994) c phosphorylation and activation of the IGF-I receptor in src-transformed cells. J Biol Chem 269: 27315-27321.
47. Peterson JE, Kulik G, Jelinek T, Reuter CW, Shannon JA, et al. (1996) Src phosphorylates the insulin-like growth factor type I receptor on the autophosphorylation sites. Requirement for transformation by src. J Biol Chem 271: 31562-31571.
48. Chen J, Capozza F, Wu A, Deangelis T, Sun H, et al. (2008) Regulation of insulin receptor substrate-1 expression levels by caveolin-1. J Cell Physiol 217: 281-289.
49. Salani B, Briatore L, Garibaldi S, Cordera R, Maggi D, (2008) Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts. Endocrinology 149: 461-465.
50. Glait C, Tencer L, Ravid D, Sarfstein R, Liscovitch M, et al. (2006) Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways. Exp Cell Res 312: 3899-3908.
51. Hong S, Huo H, Xu J, Liao K, (2004) Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae. Cell Death Differ 11: 714-723.
52. Matthews LC, Taggart MJ, Westwood M, (2008) Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I. Endocrinology. 149: 5199-5208.
53. Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, et al. (2000) Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol 14: 1750-1775.
54. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS, (1988) Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263: 9402-9408.
55. Tontonoz P, Hu E, Spiegelman BM, (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipidactivated transcription factor. Cell 79: 1147-1156.
56. Kubota N, Terauchi Y, Miki H, Tamemoto H, Komeda K, et al. (1999) PPAR gamma mediates high-fat diet-induced hypertrophy and insulin resistance. Mol. Cell 4: 597-609.
57. Freytag SO, Paielli DL, Gilbert JD (1994). Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8: 1654-1663.251665408.